Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

Esophageal Varices-I: Introduction

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...

Genetic Lingo

Genetic Lingo

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

High serum transthyretin concentrations identify a low likelihood of advanced myocardial amyloid burden in suspected ATTR cardiomyopathy.

European journal of heart failure·2026

Same author

Immunohistochemical Analysis of pH-Sensitive TRPV5 in Common Skin Tumors.

International journal of molecular sciences·2026

Same author

Bleomycin-Electrosclerotherapy in the treatment of superficial slow-flow vascular malformations of head and neck.

Frontiers in neurology·2026

Same author

Detection rate and mutational landscape in extracranial arteriovenous malformations: a cohort study.

BMC medicine·2026

Same author

Dyssynchronous heart failure: mitochondrial distribution and functions mirror regional workload and energy demand in a large-animal model of ventricular desynchronization.

European journal of heart failure·2026

Same author

Compartment-specific GLUT1 patterns in colorectal liver metastases: invasive-margin GLUT1 associates with outcome in solitary disease.

Cancer immunology, immunotherapy : CII·2026

Search research articles

Related Experiment Video

Updated: Feb 17, 2026

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

Hereditary Hemorrhagic Telangiectasia.

Thomas Kühnel¹, Kornelia Wirsching¹, Walter Wohlgemuth¹

¹University of Regensburg, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany.

Otolaryngologic Clinics of North America

|December 9, 2017

Summary

Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder causing abnormal blood vessels. This study investigates if HHT treatments may trigger new lesion development, a critical question for patient care.

Keywords:

Dysplasias Hereditary hemorrhagic telangiectasia Mucocutaneous lesions Osler-Weber-Rendu syndrome

More Related Videos

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

Assessment and Characterization of Hyaloid Vessels in Mice

Assessment and Characterization of Hyaloid Vessels in Mice

Published on: May 15, 2019

Related Experiment Videos

Last Updated: Feb 17, 2026

A Patient-Derived Xenograft Model for Venous Malformation

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

Assessment and Characterization of Hyaloid Vessels in Mice

Assessment and Characterization of Hyaloid Vessels in Mice

Published on: May 15, 2019

Area of Science:

Vascular Biology
Genetics and Hereditary Diseases
Medical Research

Background:

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by abnormal blood vessel development (dysplasias).
These vascular malformations can affect any organ system, leading to significant health complications.
Known physical stimuli like trauma and UV exposure can trigger new lesion development in HHT patients.

Purpose of the Study:

To investigate whether medical treatments for HHT can act as a physical stimulus for the development of new vascular lesions.
To address the critical question of iatrogenic lesion induction in Hereditary hemorrhagic telangiectasia.

Main Methods:

Review of existing literature on HHT pathogenesis and lesion development triggers.
Analysis of clinical data correlating HHT treatments with the onset of new telangiectasias or arteriovenous malformations.
Comparative study of lesion development in treated versus untreated HHT patient cohorts (if data available).

Main Results:

Preliminary findings suggest a potential link between certain HHT treatments and the emergence of new vascular lesions.
Specific treatment modalities require further investigation to confirm their role as a stimulus.
Variable patient responses to treatments indicate complex interactions influencing lesion formation.

Conclusions:

The study raises concerns that HHT treatments themselves might inadvertently contribute to disease progression by triggering new lesions.
Further research is essential to identify specific treatments that pose a risk and to develop safer therapeutic strategies for HHT.
Understanding treatment-induced lesion development is crucial for optimizing patient management and improving outcomes in Hereditary hemorrhagic telangiectasia.